NCT02194738 2026-03-18
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
Clinical Trials
16 trialsNCT06576635 2026-01-20
LUNG-05
University of Illinois at Chicago
Phase NA Recruiting
NCT06304441 2025-09-29
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
Guangzhou Medical University
Phase NA Recruiting
NCT06643000 2025-03-06
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
Henan Cancer Hospital
Phase NA Recruiting
NCT06649448 2024-10-18
EF-001
Shandong Cancer Hospital and Institute
Phase NA Not yet recruiting
NCT04552613 2024-01-16
Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase NA Completed
NCT05527808 2023-06-08
A Single-arm Exploratory Study of Neoadjuvant Therapy
Guangzhou Institute of Respiratory Disease
Phase NA Unknown
NCT05305885 2022-09-30
Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis
The First Hospital of Jilin University
Phase NA Unknown
NCT01063283 2019-11-18
AVF4759
University of Chicago
Phase NA Completed
NCT03671538 2018-09-17
Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin
The First Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT03489616 2018-04-05
CRAGMOLC
Shandong Cancer Hospital and Institute
Phase NA Unknown
NCT02148380 2016-04-20
Combination of Chemotherapy and Gefitinib as First-line Treatment
Shanghai Chest Hospital
Phase NA Completed
NCT01209520 2015-02-24
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
University of Miami
Phase NA Completed
NCT01860508 2013-07-08
A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers
Fudan University
Phase NA Unknown
NCT01004601 2009-10-30
Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer
Chang Gung Memorial Hospital
Phase NA Completed
NCT00903292 2009-05-18
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
National Cheng-Kung University Hospital
Phase NA Unknown